Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定SAH后迟发性脑血管痉挛的治疗目标
基本信息
- 批准号:8874313
- 负责人:
- 金额:$ 1.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2015-08-14
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdoptive TransferAffectAneurysmAntibodiesAreaBehavioralBiologyBlood VesselsBlood coagulationBrainBrain AneurysmsBrain InjuriesCerebral IschemiaCerebrovascular SpasmCharacteristicsClinical Investigator AwardClinical TrialsComplicationDataDeteriorationDevelopmentFundingGenesGoalsGrantHemorrhageHippocampus (Brain)HumanHypoglycemiaHypoxiaIL8RB geneInflammationInflammatoryInjuryInterferonsInterleukin-8B ReceptorIntracranial AneurysmIschemiaKnockout MiceKnowledgeLaboratoriesLeadLong-Term PotentiationMediatingModelingMonoclonal AntibodiesMorbidity - disease rateMusMyeloid CellsNeuraxisNeurologicNeurologic DysfunctionsNeuronal InjuryNeuronsOutcomePathway interactionsPatientsPerformancePeritoneumPharmaceutical PreparationsPoly I-CPopulationPreventionRecruitment ActivityResearchResearch ProposalsRoleRuptureRuptured AneurysmScientistSeriesSliceSpasmStrokeSubarachnoid HemorrhageSubarachnoid SpaceSynapsesSyndromeTestingThioglycolatesTimeTissuesUnited States National Institutes of HealthVasospasmWild Type MouseWorkbasebehavioral outcomeconstrictiondisabilityhuman diseaseimprovedmigrationmouse developmentmouse modelneutrophilnovelpresynapticpreventreconstitutionresearch studyresponsetherapy developmenttreatment strategyvasoconstriction
项目摘要
DESCRIPTION (provided by applicant): The goal of this research proposal is to investigate the role of neutrophils in the development of delayed neurologic deterioration (DND) after subarachnoid hemorrhage (SAH). The research strategy utilizes a novel and unique mouse model of SAH and a newly described inducible CXCR2 knockout mouse. The model of SAH was developed during funding from an NIH scientist development grant (K08) mechanism. The overall hypothesis is that the development of DND is mediated by recruited neutrophils entering the CNS after SAH and from neutrophil effector mechanisms once in the CNS. Performance of this research will advance current knowledge in three ways: 1) It will characterize the specific neuronal changes developed during SAH and determine the role of neutrophils in neuronal injury. It will clarify the role of the recruited neutrophil population in the development of DND tat is critical to understanding whether prevention of neutrophil entry into the CNS after SAH will be a target for treatment, and SAH. And finally it will help answer the question of whether medications administered after SAH that block neutrophils will be useful to treat DND. The Specific Aims are: 1: We will define the role of neutrophils in neuronal damage after SAH.. 2: We will reconstitute migration and effector function-competent neutrophils in CXCR2 deficient mice at multiple time points AFTER SAH to define the role of the recruited neutrophils in DND. 3: We will deplete neutrophils at time points after the SAH to define the critical times for neutrophil damage in SAH. This knowledge will identify targets for treatment in SAH and DND.
描述(由申请人提供):本研究计划的目的是研究中性粒细胞在蛛网膜下腔出血(SAH)后延迟性神经功能恶化(DND)发展中的作用。该研究策略利用了一种新颖独特的SAH小鼠模型和一种新描述的诱导型CXCR2敲除小鼠。SAH模型是在NIH科学家发展资助(K08)机制的资助下开发的。总的假设是,DND的发展是由SAH后进入中枢神经系统的募集中性粒细胞和进入中枢神经系统后的中性粒细胞效应机制介导的。本研究的表现将在三个方面推进现有的知识:1)它将表征SAH期间发展的特定神经元变化,并确定中性粒细胞在神经元损伤中的作用。它将阐明招募的中性粒细胞群体在DND发展中的作用,这对于理解预防SAH后中性粒细胞进入中枢神经系统是否将成为治疗和SAH的目标至关重要。最后,它将有助于回答SAH后给予阻断中性粒细胞的药物是否对治疗DND有用的问题。具体目的是:1:我们将明确中性粒细胞在SAH后神经元损伤中的作用。我们将在SAH后的多个时间点重建CXCR2缺陷小鼠的迁移和具有效应功能的中性粒细胞,以确定募集的中性粒细胞在DND中的作用。我们将在SAH后的时间点消耗中性粒细胞,以确定SAH中性粒细胞损伤的临界时间。这些知识将确定SAH和DND的治疗目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose Javier Provencio其他文献
Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: The Role of the Complement and Innate Immune System
- DOI:
10.1007/s12975-024-01290-5 - 发表时间:
2024-08-21 - 期刊:
- 影响因子:4.300
- 作者:
Jose Javier Provencio;Sonya Inkelas;Mervyn D. I. Vergouwen - 通讯作者:
Mervyn D. I. Vergouwen
Correction to: Proceedings of the Second Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness
- DOI:
10.1007/s12028-022-01536-w - 发表时间:
2022-06-17 - 期刊:
- 影响因子:3.600
- 作者:
Shraddha Mainali;Venkatesh Aiyagari;Sheila Alexander;Yelena Bodien;Varina Boerwinkle;Melanie Boly;Emery Brown;Jeremy Brown;Jan Claassen;Brian L. Edlow;Ericka L. Fink;Joseph J. Fins;Brandon Foreman;Jennifer Frontera;Romergryko G. Geocadin;Joseph Giacino;Emily J. Gilmore;Olivia Gosseries;Flora Hammond;Raimund Helbok;J. Claude Hemphill;Karen Hirsch;Keri Kim;Steven Laureys;Ariane Lewis;Geoffrey Ling;Sarah L. Livesay;Victoria McCredie;Molly McNett;David Menon;Erika Molteni;DaiWai Olson;Kristine O’Phelan;Soojin Park;Len Polizzotto;Jose Javier Provencio;Louis Puybasset;Chethan P. Venkatasubba Rao;Courtney Robertson;Benjamin Rohaut;Michael Rubin;Tarek Sharshar;Lori Shutter;Gisele Sampaio Silva;Wade Smith;Robert D. Stevens;Aurore Thibaut;Paul Vespa;Amy K. Wagner;Wendy C. Ziai;Elizabeth Zink;Jose I. Suarez - 通讯作者:
Jose I. Suarez
Small Molecule Myeloperoxidase (MPO) Inhibition Prevents Delayed Cerebral Injury (DCI) After Subarachnoid Hemorrhage (SAH) in a Murine Model
- DOI:
10.1007/s12028-024-02169-x - 发表时间:
2024-12-10 - 期刊:
- 影响因子:3.600
- 作者:
Safiye Limon;Aminata P. Coulibaly;Jose Javier Provencio - 通讯作者:
Jose Javier Provencio
ICP Monitoring for Bacterial Meningitis: Is This Just One of the Blind Spots in Neurocritical Care?
- DOI:
10.1007/s12028-024-01940-4 - 发表时间:
2024-02-17 - 期刊:
- 影响因子:3.600
- 作者:
Jose Javier Provencio - 通讯作者:
Jose Javier Provencio
Jose Javier Provencio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose Javier Provencio', 18)}}的其他基金
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定SAH后迟发性脑血管痉挛的治疗目标
- 批准号:
9165688 - 财政年份:2015
- 资助金额:
$ 1.77万 - 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定 SAH 后迟发性脑血管痉挛的治疗目标
- 批准号:
8485699 - 财政年份:2012
- 资助金额:
$ 1.77万 - 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定SAH后迟发性脑血管痉挛的治疗目标
- 批准号:
8703818 - 财政年份:2012
- 资助金额:
$ 1.77万 - 项目类别:
Defining targets for the treatment of delayed cerebral vasospasm after SAH
确定 SAH 后迟发性脑血管痉挛的治疗目标
- 批准号:
8297484 - 财政年份:2012
- 资助金额:
$ 1.77万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 1.77万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 1.77万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 1.77万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 1.77万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 1.77万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 1.77万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 1.77万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 1.77万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 1.77万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 1.77万 - 项目类别:














{{item.name}}会员




